Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., today announced that the U.S. Food and Drug Administration approved EDARBI for the treatment of hypertension, or high blood pressure, in adults.

BRUSSELS and VIENNA , February 28, 2011 /PRNewswire/ -- - Little-known but Life-Threatening Condition Literally Takes the Breath Away From Several Million People Globally[1] Events taking place today in Brussels and Vienna mark the launch of a new European campaign to raise awareness of pulmonary hypertension (PH), a condition characterized by high blood pressure in the arteries of the lungs ...

-

The British Hypertension Society website lists all the blood pressure monitors that have been issued with validation. The First Aid Warehouse now stocks BHS validated blood pressure monitors.

Read the full story at http://www.prweb.com/releases/2007/10/prweb562639.htm

Edarbi tablets (azilsartan medoxomil) for the treatment of high blood pressure (hypertension) in adults has been approved by the Food and Drug Administration (FDA), USA. The FDA says it approved Edarbi after examining data from clinical studies which clearly demonstrated Edarbi's superior efficacy compared to two already FDA-approved medications - Benicar (olmesartan) and Diovan (valsartan ...